Zim To Introduce HIV Prevention Drug Thats Taken Once Every Month

Dr Nyaradzo Mgodi MBChB, MMed, Investigator of Record, HPTN-084 Zimbabwe – University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, and HPTN Executive Committee Member

ZIMBABWE is among the first countries set to introduce a new HIV preventative drug that will be taken once a month in a move that is likely to expand HIV prevention options for citizens. By Patricia Mashiri The new drug, Islatravir (MK-8591) belongs to a class of drugs called First-in-Class Nucleoside Reverse Transcriptase Translocation Inhibitor (NRTTI) With Multiple Mechanisms of Action. These multiple mechanisms of action contribute to its high potency against HIV-1 and drug-resistant variants, and its high barrier to resistance. Dr Nyaradzo Mgodi, Principal Investigator, University of Zimbabwe’s…

Read More